Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Offermann

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
American Journal of Nephrology|January 1, 1996
Severe calciphylaxis in a renal patient on long-term oral anticoagulant therapyM Rudwaleit, A Schwarz, C Trautmann, et al.
American Journal of Nephrology|January 1, 1988
Elevated tumor markers in hemodialysis patientsG Walz, U Kunzendorf, F Keller, et al.
Therapeutic Drug Monitoring|June 1, 1987
Therapeutic aminoglycoside monitoring in renal failure patientsF Keller, K Borner, A Schwarz, et al.
Zeitschrift Fur Urologie Und Nephrologie|October 1, 1986
[Preventive use of antibiotics in kidney transplantation]H Wilms, F Keller, J Hasselmann, et al.
Clinical Nephrology|April 1, 1989
Long-term treatment and prognosis of rapidly progressive glomerulonephritisF Keller, B Oehlenberg, U Kunzendorf, et al.
Transplantation|September 1, 1989
Neurotoxicity caused by a high cyclosporine metabolite levelU Kunzendorf, J Brockmöller, F Jochimsen, et al.
Transplantation|August 27, 1995
Pharmacokinetics of methylprednisolone and rejection episodes in kidney transplant patientsF Keller, T Hemmen, M Schöneshöfer, et al.
Lancet (London, England)|January 25, 1986
Analgesic nephropathy in West GermanyA Schwarz, U Faber, G Glaeske, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1990
Slow accumulation of cyclosporin metabolites as measured by specific and nonspecific cyclosporin RIAF Keller, U Kunzendorf, G Walz, et al.
Transplantation Proceedings|August 1, 1990
Activity of cyclosporin metabolites M17 and M1U Kunzendorf, J Brockmöller, F Jochimsen, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
American Journal of Nephrology|January 1, 1996
Severe calciphylaxis in a renal patient on long-term oral anticoagulant therapyM Rudwaleit, A Schwarz, C Trautmann, et al.
American Journal of Nephrology|January 1, 1988
Elevated tumor markers in hemodialysis patientsG Walz, U Kunzendorf, F Keller, et al.
Therapeutic Drug Monitoring|June 1, 1987
Therapeutic aminoglycoside monitoring in renal failure patientsF Keller, K Borner, A Schwarz, et al.
Zeitschrift Fur Urologie Und Nephrologie|October 1, 1986
[Preventive use of antibiotics in kidney transplantation]H Wilms, F Keller, J Hasselmann, et al.
Clinical Nephrology|April 1, 1989
Long-term treatment and prognosis of rapidly progressive glomerulonephritisF Keller, B Oehlenberg, U Kunzendorf, et al.
Transplantation|September 1, 1989
Neurotoxicity caused by a high cyclosporine metabolite levelU Kunzendorf, J Brockmöller, F Jochimsen, et al.
Transplantation|August 27, 1995
Pharmacokinetics of methylprednisolone and rejection episodes in kidney transplant patientsF Keller, T Hemmen, M Schöneshöfer, et al.
Lancet (London, England)|January 25, 1986
Analgesic nephropathy in West GermanyA Schwarz, U Faber, G Glaeske, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1990
Slow accumulation of cyclosporin metabolites as measured by specific and nonspecific cyclosporin RIAF Keller, U Kunzendorf, G Walz, et al.
Transplantation Proceedings|August 1, 1990
Activity of cyclosporin metabolites M17 and M1U Kunzendorf, J Brockmöller, F Jochimsen, et al.
Pageof 14